The CR2 gene helps B cells, a type of white blood cell, recognize germs that have been tagged for attention and build an antibody response. This gene plays an important role in how your immune system fine tunes defense against infection. If the CR2 gene does not work properly, some people may have weaker immune responses, repeated infections, or a higher chance of autoimmune conditions such as lupus. The CR2 protein is also known as CD21 and can act as an entry point for Epstein-Barr virus into B cells.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or guiding activities in the body. Some genes carry the code for proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they take place, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
CR2Gene function
What if the gene works
The CR2 gene helps certain white blood cells called B cells recognize germs marked by the immune system. This supports antibody production and immune memory.
Risk
What if the gene does not work
More disruptive variants in the CR2 gene can reduce B cell signaling and antibody responses, leading to low antibody levels and repeated infections. Milder variants may have smaller effects or may influence the chance of immune conditions such as lupus.
Treatment
What does that mean for your treatment
No CR2-specific treatment or management approach is currently established. In research, the CR2 gene and its protein product, CD21, are being studied as possible biomarkers and treatment targets in some immune and B cell conditions.
Conditions associated with CR2
Gene function
What if the gene works
Much of the CR2 gene’s day to day work happens in the immune system, where cells need to notice germs without overreacting. It helps certain immune cells read complement tags, which are small protein markers placed on microbes and other targets. This background helps explain what the CR2 gene does in B cells as they start and shape antibody responses.
The CR2 gene helps B cells recognize targets that have been marked by complement, a set of immune proteins that tag material for attention. This gives the immune system a clearer read of what should be checked and can support a more focused antibody response.
Inside B cells, the CR2 gene works with partner proteins such as CD19 and CD81 to strengthen activation signals. This lets a small outside cue become a steadier message inside the cell.
The CR2 gene also helps certain immune cells in lymph nodes hold onto complement tagged material for longer. This gives B cells repeated chances to study those targets and build lasting antibody memory.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CR2 gene can change the CD21 protein so it is shortened, unstable, or does not reach the cell surface normally. Some milder CR2 gene variants mainly reduce how much protein is made, while more severe variants may stop the protein from working or from binding its usual partners. This range in functional effect can help explain why the impact of a variant differs from one person to another.
How variants are linked to conditions
Pathogenic variants in the CR2 gene can cause a rare antibody deficiency with repeated infections, low antibody levels, and weaker responses to vaccines. Some people also have enlarged lymph nodes or an enlarged spleen. Separate from this diagnosis, several common CR2 gene variants have been linked to conditions such as systemic lupus erythematosus in population studies, but these associations reflect risk rather than certainty.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant connected with a condition suggests a possible association rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce health risk related to the CR2 gene itself. Overall risk usually depends on the exact genetic change, family history, and other parts of health and environment, so personal concerns are best discussed with a doctor or genetic counselor.
Inheritance of CR2 variants
For families asking how CR2 gene variants are inherited, the well-established pattern is autosomal recessive for CR2-related CD21 deficiency. This means a person usually inherits one CR2 gene variant from each parent. Parents who carry one variant are often unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child who inherits neither variant.
What does my CR2 result mean for my family?
For CR2, the clearest family pattern is recessive, which means close relatives may carry the same change even if they feel well. Brothers and sisters could also be affected or be carriers, and parents are often healthy carriers. The meaning for other relatives depends on the exact CR2 result and the condition linked to it.
Genetic information
Genetic testing
How you find out about variants
CR2 genetic testing looks for variants in the CR2 gene using DNA from a blood sample, saliva, or a cheek swab. A lab reads the gene's code and reports whether a variant was found, which can help clarify whether a specific inherited change is present.
When should I consider getting a genetic test?
Genetic testing for the CR2 gene may be considered when someone has repeated serious infections, very low antibody levels, or a family history of an inherited immune condition. In most other situations, testing decisions are best made with a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic results can offer useful insight, but how much they reveal depends on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment, yet one may get the intended benefit while the other may notice less effect or more side effects. This happens in part because inherited differences can change how the body breaks down, moves, or responds to a drug. These differences are common and are one reason medication response is not the same for everyone.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic variation can affect the way a person responds to medicines. By studying links between genes and medications, it helps clarify why the same treatment may work differently from one person to another. For many drugs, genes can influence both how strongly a medicine works and how the body handles it. This understanding can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the CR2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dosing. If you have questions about side effects, how well a treatment is working, or any other health concerns, talk with your doctor or pharmacist.
History
Research on the CR2 gene took shape in the late 20th century as immunologists worked to map key markers on the surface of immune cells. In the 1980s, the protein linked to this gene was identified as CD21, which gave scientists a clearer way to classify certain B cells in the lab. A major milestone followed when CD21 was recognized as the main receptor used by Epstein-Barr virus to attach to human B cells, drawing wider attention to the gene. From these first observations, research expanded steadily. As laboratory methods improved, the CR2 gene became part of broader efforts to understand immune signaling, autoimmunity, and lymphoma biology. Its history is closely tied to the rise of modern immunology and virus research.